Search Results
Dr. Sharman on the Design of the ELEVATE-TN Trial in CLL
Key Takeaways from the ELEVATE-TN Trial in CLL
What has the presentation of the ELEVATE TN trial taught us?
Dr. Pagel on the ELEVATE-TN Trial in CLL
Dr. Woyach on the Results of the ELEVATE-TN Trial
ELEVATE-TN Shows Acalabrutinib Is Well-Tolerated in CLL
ELEVATE-TN: approval of acalabrutinib for adult CLL
ELEVATE TN: Comparing acalabrutinib monotherapy or in combination with obinutuzumab in treatment...
Dr. Sharman on the Challenges of Adjusting Treatment Based on MRD Status in CLL
Jeffrey Sharman, MD, tells us about the design and outcomes of the Phase 3 ELEVATE TN from ASH 2019
Dr. Cohen on the ELEVATE-TN Trial in CLL
ASH 2013: Dr Jeff Sharman Discusses the Ideal Design of Phase 3 Trials with Novel Agent.
